HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HAIXI PHARMA

166.000

-1.000-0.60%

Volume:86.40K

Turnover:14.67M

Market Cap:13.07B

PE:55.72

High:173.700

Open:167.100

Low:166.000

Close:167.000

52wk High:302.400

52wk Low:97.500

Shares:78.71M

HK Float Shares:78.71M

Volume Ratio:1.83

T/O Rate:0.11%

Dividend:- -

Dividend Rate:- -

EPS(LYR):2.979

ROE:16.58%

ROA:9.23%

PB:6.70

PE(LYR):55.72

PS:18.83

Loading ...

Overview Company News Filings

Haixi Pharmaceuticals Launches Phase III Trial of First-in-Class C019199 Tablets for Refractory Osteosarcoma

Bulletin Express

Haixi Pharmaceuticals Launches Phase III Trial of C019199 Tablet in Osteosarcoma

Fujian Haixi Pharmaceuticals Co - Launches Phase Iii Clinical Trial of C019199 Tablets for Osteosarcoma

THOMSON REUTERS

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress

HAIXI PHARMA Shareholders Deposit Nearly 10 Million Shares with CMB International Securities

CMB International Initiates Coverage on Haixi Pharma with 'Buy' Rating and HK$280 Target

HAIXI PHARMA Finalises New Articles of Association to Support Upcoming H-Share Listing and Strengthen Governance

Bulletin Express

HAIXI PHARMA Releases Updated Board Procedure Rules to Strengthen Governance Framework

Bulletin Express

HAIXI PHARMA (02637) Announces New Board Appointments and Leadership Changes

Fujian Haixi Pharmaceuticals files directors list with Hong Kong Stock Exchange

Fujian Haixi Pharma amends articles, scraps board of supervisors in governance overhaul

Movement Alert｜Haixi New Drug Rises 5.37% in Regular Trading, Recovery Extends on Strong Annual Results and Broker Coverage

HAIXI PHARMA Registers Stable Share Base in April; Confirms Public Float Compliance

Bulletin Express

Stock Track | Haixi Pharma Soars 5.74% Intraday on Strong Annual Results and Broker Buy Rating

Stock Track | HAIXI PHARMA Plummets 8.35% Intraday on Lock-up Expiry Selling and Correction from Historical Highs

Haixi Pharma Sets 27 May 2026 AGM; Agenda Covers 19 Proposals Including Board Restructure, No 2025 Dividend and New Share Incentive Scheme

Bulletin Express

Haixi Pharma announces 27 May 2026 AGM; agenda covers capital increase, governance overhaul and new share mandates

Bulletin Express

Haixi Pharma Schedules 27 May 2026 AGM; Agenda Covers 2025 Results, Board Restructure and New Share Mandates

Bulletin Express

Fujian Haixi Pharmaceuticals announces annual general meeting

Stock Track | Haixi Pharma Soars 9.54% Intraday on Share Incentive Plan Announcement and Strong Fundamentals

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/02637/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","market":"HK","secType":"STK","nameCN":"HAIXI PHARMA","latestPrice":166,"timestamp":1790755707004,"preClose":167,"halted":0,"volume":86400,"delay":0,"changeRate":-0.005988023952095809,"floatShares":78707270,"shares":78707270,"eps":2.9794446231455405,"marketStatus":"Not Yet Opened","change":-1,"latestTime":"09-30 16:08:27","open":167.1,"high":173.7,"low":166,"amount":14669567,"amplitude":0.046108,"askPrice":166.8,"askSize":250,"bidPrice":166,"bidSize":900,"shortable":3,"etf":0,"ttmEps":2.333067548865161,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":0,"adr":0,"listingDate":1760889600000,"exchange":"SEHK","adjPreClose":167,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":1.8328383518955893,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","floatShares":78707270,"roa":"9.23%","roe":"16.58%","lyrEps":2.979445,"volumeRatio":1.8328383518955893,"shares":78707270,"dividePrice":0,"high":173.7,"amplitude":0.046108,"preClose":167,"low":166,"week52Low":97.5,"pbRate":"6.70","psRate":"18.83","week52High":302.4,"institutionHeld":0,"latestPrice":166,"committee":0.565217,"eps":2.9794446231455405,"divideRate":0,"volume":86400,"delay":0,"ttmEps":2.333067548865161,"open":167.1,"prevYearClose":136,"prevWeekClose":172,"prevMonthClose":166,"prevQuarterClose":166,"fiveDayClose":175.6,"twentyDayClose":198.3,"sixtyDayClose":203},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02637\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-30","symbol":"02637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02637\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1781107200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02637","date":"2026-09-30","current":71.168064,"percent":0.562232,"low":41.43616,"twenty":68.63795,"median":73.127384,"eighty":81.974281,"high":108.687128,"avg":74.78197,"sd":9.248122,"marketCap":13065406820},"quantilePoints":[{"date":"2025-10-16","current":41.43616,"twenty":41.43616,"median":41.43616,"eighty":41.43616,"marketCap":6150186077},{"date":"2025-10-24","current":58.044665,"twenty":53.788314,"median":54.742854,"eighty":58.044665,"marketCap":8618446065},{"date":"2025-10-31","current":63.409996,"twenty":54.11413,"median":58.177187,"eighty":60.582738,"marketCap":9429130946},{"date":"2025-11-07","current":65.038519,"twenty":55.071217,"median":59.875924,"eighty":63.533346,"marketCap":9665252756},{"date":"2025-11-14","current":69.713569,"twenty":57.493757,"median":61.562796,"eighty":68.778725,"marketCap":10389359640},{"date":"2025-11-21","current":66.575785,"twenty":58.2567,"median":64.026746,"eighty":69.208194,"marketCap":9917116020},{"date":"2025-11-28","current":68.072175,"twenty":59.478322,"median":65.807152,"eighty":68.767812,"marketCap":10176850011},{"date":"2025-12-05","current":68.42835,"twenty":59.854834,"median":66.893861,"eighty":68.767812,"marketCap":10247686554},{"date":"2025-12-12","current":69.403659,"twenty":60.326406,"median":67.279459,"eighty":69.361692,"marketCap":10412971821},{"date":"2025-12-19","current":69.502155,"twenty":61.237436,"median":67.861589,"eighty":69.423358,"marketCap":10452325456},{"date":"2025-12-24","current":72.521094,"twenty":61.537644,"median":68.055113,"eighty":69.462757,"marketCap":10940310530},{"date":"2026-01-02","current":68.547,"twenty":62.032842,"median":68.254334,"eighty":69.697511,"marketCap":10381488913},{"date":"2026-01-09","current":76.256401,"twenty":63.533346,"median":68.54394,"eighty":70.33117,"marketCap":11577839417},{"date":"2026-01-16","current":83.450154,"twenty":64.030428,"median":68.594109,"eighty":71.180851,"marketCap":12711224105},{"date":"2026-01-23","current":75.203122,"twenty":64.243828,"median":68.851274,"eighty":73.407226,"marketCap":11444037058},{"date":"2026-01-30","current":72.029156,"twenty":65.345972,"median":69.26967,"eighty":73.580372,"marketCap":11011147073},{"date":"2026-02-06","current":69.741329,"twenty":66.631937,"median":69.18814,"eighty":73.524909,"marketCap":10688447266},{"date":"2026-02-13","current":69.700471,"twenty":66.864009,"median":69.376262,"eighty":73.289662,"marketCap":10743542355},{"date":"2026-02-20","current":69.085102,"twenty":66.878935,"median":69.376262,"eighty":72.984771,"marketCap":10633352177},{"date":"2026-02-27","current":72.331605,"twenty":67.046254,"median":69.403659,"eighty":72.584608,"marketCap":11255139610},{"date":"2026-03-06","current":63.89376,"twenty":67.046254,"median":69.448144,"eighty":72.584608,"marketCap":9862020931},{"date":"2026-03-13","current":75.4784,"twenty":67.193436,"median":69.633279,"eighty":73.562991,"marketCap":11703771049},{"date":"2026-03-20","current":69.956787,"twenty":67.26348,"median":69.715081,"eighty":73.483508,"marketCap":10806508171},{"date":"2026-03-27","current":78.768036,"twenty":67.31702,"median":69.741329,"eighty":73.616705,"marketCap":12136661034},{"date":"2026-04-02","current":69.050489,"twenty":67.448055,"median":69.756887,"eighty":73.953025,"marketCap":13907574609},{"date":"2026-04-10","current":75.734842,"twenty":67.617502,"median":69.89051,"eighty":74.51958,"marketCap":15371529831},{"date":"2026-04-17","current":75.664292,"twenty":67.861589,"median":70.029272,"eighty":74.51958,"marketCap":15363659104},{"date":"2026-04-24","current":92.094347,"twenty":68.038051,"median":70.361759,"eighty":74.892793,"marketCap":18700847352},{"date":"2026-04-30","current":101.138303,"twenty":68.06535,"median":70.518529,"eighty":75.515578,"marketCap":20542597470},{"date":"2026-05-08","current":91.134409,"twenty":68.133872,"median":70.614497,"eighty":76.472636,"marketCap":18574915720},{"date":"2026-05-15","current":84.578883,"twenty":68.178204,"median":70.813553,"eighty":78.193464,"marketCap":17284116492},{"date":"2026-05-22","current":93.496946,"twenty":68.295676,"median":71.108793,"eighty":80.407586,"marketCap":19062900794},{"date":"2026-05-29","current":86.09458,"twenty":68.386305,"median":71.340959,"eighty":80.936301,"marketCap":17614687026},{"date":"2026-06-05","current":72.717092,"twenty":68.497704,"median":72.103769,"eighty":80.766638,"marketCap":14899286211},{"date":"2026-06-12","current":67.961351,"twenty":68.497704,"median":71.340959,"eighty":80.580489,"marketCap":13915445336},{"date":"2026-06-18","current":66.149737,"twenty":68.365282,"median":71.108793,"eighty":80.547429,"marketCap":13577004075},{"date":"2026-06-26","current":64.123676,"twenty":68.103023,"median":70.813553,"eighty":80.470686,"marketCap":13096889728},{"date":"2026-07-03","current":76.78307,"twenty":68.156523,"median":70.813553,"eighty":80.277662,"marketCap":15694229638},{"date":"2026-07-10","current":79.190679,"twenty":68.212992,"median":71.108793,"eighty":80.277662,"marketCap":16166473258},{"date":"2026-07-17","current":71.84101,"twenty":68.34426,"median":71.590985,"eighty":79.86919,"marketCap":14718259490},{"date":"2026-07-24","current":70.518964,"twenty":68.451468,"median":71.287767,"eighty":79.796901,"marketCap":14450654772},{"date":"2026-07-31","current":65.554893,"twenty":68.149296,"median":70.906272,"eighty":79.747346,"marketCap":13458943170},{"date":"2026-08-07","current":75.261161,"twenty":68.149296,"median":71.19828,"eighty":79.190679,"marketCap":15481720009},{"date":"2026-08-14","current":78.261297,"twenty":68.185431,"median":71.340959,"eighty":78.768036,"marketCap":16119248896},{"date":"2026-08-21","current":76.639812,"twenty":68.323237,"median":72.054899,"eighty":79.190679,"marketCap":15820161270},{"date":"2026-08-28","current":74.907011,"twenty":68.42835,"median":72.201471,"eighty":78.768036,"marketCap":15465978555},{"date":"2026-09-04","current":89.46632,"twenty":68.54394,"median":72.352576,"eighty":79.884165,"marketCap":15686358911},{"date":"2026-09-11","current":86.521471,"twenty":68.545014,"median":72.521094,"eighty":80.616434,"marketCap":15190503110},{"date":"2026-09-18","current":86.274256,"twenty":68.547,"median":72.698486,"eighty":82.359485,"marketCap":15166890929},{"date":"2026-09-25","current":77.153646,"twenty":68.63305,"median":72.884321,"eighty":82.34846,"marketCap":13537650440},{"date":"2026-09-30","current":74.32358,"twenty":68.63795,"median":73.127384,"eighty":81.974281,"marketCap":13065406820}],"updateTime":1790853320507},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02637\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1104564655","title":"Haixi Pharmaceuticals Launches Phase III Trial of First-in-Class C019199 Tablets for Refractory Osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1104564655","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104564655?lang=en_us&edition=fundamental","pubTime":"2026-07-09 16:40","pubTimestamp":1783586437,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (Haixi Pharmaceuticals) has formally commenced a multicenter, randomized, controlled, open-label Phase III clinical study (Protocol HXP019-CTPIII-02) to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650384947","title":"Haixi Pharmaceuticals Launches Phase III Trial of C019199 Tablet in Osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2650384947","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650384947?lang=en_us&edition=fundamental","pubTime":"2026-07-09 16:37","pubTimestamp":1783586240,"startTime":"0","endTime":"0","summary":"Haixi Pharmaceuticals launches Phase III trial of C019199 tablet in osteosarcomaFujian Haixi Pharmaceuticals initiated a Phase III trial of C019199 tablets in osteosarcoma patients who failed at least","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDLbnNnVb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650394782","title":"Fujian Haixi Pharmaceuticals Co - Launches Phase Iii Clinical Trial of C019199 Tablets for Osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2650394782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650394782?lang=en_us&edition=fundamental","pubTime":"2026-07-09 16:36","pubTimestamp":1783586169,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nFWN43B0JO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149233574","title":"Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149233574","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149233574?lang=en_us&edition=fundamental","pubTime":"2026-07-06 09:58","pubTimestamp":1783303082,"startTime":"0","endTime":"0","summary":"Hong Kong innovative drug stocks jumped in market trading. $HAIXI PHARMA(02637)$, $INNOCARE(09969)$ up 7%; $KEYMED BIO-B(02162)$ up 5%; $REMEGEN(09995)$, $INNOVENT BIO(01801)$, $SIMCERE PHARMA(02096)$ up 4%; $LEPU BIO(02157)$ up 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969","01801","02637","SOXL","02157","09995","02162","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168595480","title":"HAIXI PHARMA Shareholders Deposit Nearly 10 Million Shares with CMB International Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1168595480","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168595480?lang=en_us&edition=fundamental","pubTime":"2026-06-22 09:07","pubTimestamp":1782090453,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, a significant change in shareholding for HAIXI PHARMA (02637) was recorded on June 18th.The total value of shares held in the relevant...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","161027","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154998341","title":"CMB International Initiates Coverage on Haixi Pharma with 'Buy' Rating and HK$280 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1154998341","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154998341?lang=en_us&edition=fundamental","pubTime":"2026-06-10 11:08","pubTimestamp":1781060902,"startTime":"0","endTime":"0","summary":"CMB International has released a research report initiating coverage on HAIXI PHARMA (02637), assigning a 'Buy' rating and setting a target price of HK$280.The report describes HAIXI PHARMA as an...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","02637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148278143","title":"HAIXI PHARMA Finalises New Articles of Association to Support Upcoming H-Share Listing and Strengthen Governance","url":"https://stock-news.laohu8.com/highlight/detail?id=1148278143","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148278143?lang=en_us&edition=fundamental","pubTime":"2026-05-27 17:44","pubTimestamp":1779875063,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (“HAIXI PHARMA”) has released its amended Articles of Association, effective upon the planned listing of its H shares on the Stock Exchange of Hong Kong. Key...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146241795","title":"HAIXI PHARMA Releases Updated Board Procedure Rules to Strengthen Governance Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=1146241795","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146241795?lang=en_us&edition=fundamental","pubTime":"2026-05-27 17:43","pubTimestamp":1779875038,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (HAIXI PHARMA) has published the “Rules of Procedure for Meeting of the Board of Directors”, a comprehensive governance document intended to standardise...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112742027","title":"HAIXI PHARMA (02637) Announces New Board Appointments and Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1112742027","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112742027?lang=en_us&edition=fundamental","pubTime":"2026-05-27 17:40","pubTimestamp":1779874834,"startTime":"0","endTime":"0","summary":"HAIXI PHARMA (02637) has announced that Dr. Chen Shuyi and Mr. Gong Weimin have retired as directors of the board following the conclusion of the annual general meeting. During the annual general...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638505283","title":"Fujian Haixi Pharmaceuticals files directors list with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2638505283","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638505283?lang=en_us&edition=fundamental","pubTime":"2026-05-27 17:37","pubTimestamp":1779874674,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals filed an updated list of directors with the Hong Kong Stock Exchange on May 27, 2026.Board includes four executive directors, led by Chairman Dr. Kang Xinshan.Two non-executive directors serve alongside three independent non-executive directors.Committee chairs: Strategy—Dr. Kang Xinshan; Audit—Ms. Pu Meiting; Remuneration and Appraisal—Ms. Wang Shan Shan; Nomination—Ms. Wang Shan Shan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fujian Haixi Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL7qy3jr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638460505","title":"Fujian Haixi Pharma amends articles, scraps board of supervisors in governance overhaul","url":"https://stock-news.laohu8.com/highlight/detail?id=2638460505","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638460505?lang=en_us&edition=fundamental","pubTime":"2026-05-27 17:36","pubTimestamp":1779874594,"startTime":"0","endTime":"0","summary":"Shareholders on May 27, 2026 passed amendments to the articles of association, with 99.9991% of votes cast in favor.Bylaw changes abolished the board of supervisors, effective immediately; oversight duties shift to the board’s audit committee.Related procedural rules were revised, including the rules for shareholder meetings and board meetings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fujian Haixi Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL1N00gD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161926855","title":"Movement Alert｜Haixi New Drug Rises 5.37% in Regular Trading, Recovery Extends on Strong Annual Results and Broker Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=1161926855","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161926855?lang=en_us&edition=fundamental","pubTime":"2026-05-20 14:43","pubTimestamp":1779259395,"startTime":"0","endTime":"0","summary":"On May 20, Haixi New Drug (02637.HK) rose 5.37% in regular trading, trading at 248.2 HKD/share, with trading volume of approximately 28.97 million HKD. The stock extended its rebound after fully...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112962796","title":"HAIXI PHARMA Registers Stable Share Base in April; Confirms Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1112962796","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112962796?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:42","pubTimestamp":1778146968,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (HAIXI PHARMA) filed its Monthly Return with Hong Kong Exchanges and Clearing on 7 May 2026, covering movements up to 30 April 2026. The company reported no...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185030166","title":"Stock Track | Haixi Pharma Soars 5.74% Intraday on Strong Annual Results and Broker Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1185030166","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185030166?lang=en_us&edition=fundamental","pubTime":"2026-05-05 09:42","pubTimestamp":1777945362,"startTime":"0","endTime":"0","summary":"Haixi Pharma's stock surged 5.74% during intraday trading on Tuesday, marking a significant rebound.The sharp rise follows the company's release of its annual report, which showed revenue of RMB 582...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181538654","title":"Stock Track | HAIXI PHARMA Plummets 8.35% Intraday on Lock-up Expiry Selling and Correction from Historical Highs","url":"https://stock-news.laohu8.com/highlight/detail?id=1181538654","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181538654?lang=en_us&edition=fundamental","pubTime":"2026-05-04 09:58","pubTimestamp":1777859931,"startTime":"0","endTime":"0","summary":"HAIXI PHARMA's stock plummeted 8.35% during intraday trading on Monday, marking a significant decline for the pharmaceutical company.The sharp drop is primarily attributed to ongoing selling pressure...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166475230","title":"Haixi Pharma Sets 27 May 2026 AGM; Agenda Covers 19 Proposals Including Board Restructure, No 2025 Dividend and New Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1166475230","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166475230?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:43","pubTimestamp":1777556638,"startTime":"0","endTime":"0","summary":"Haixi Pharma will hold its annual general meeting on 27 May 2026 in Fuzhou, with shareholders asked to vote on 19 resolutions that together signal a comprehensive reshaping of the company’s...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186675778","title":"Haixi Pharma announces 27 May 2026 AGM; agenda covers capital increase, governance overhaul and new share mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1186675778","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186675778?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:43","pubTimestamp":1777556585,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (“Haixi Pharma”) has issued the proxy form and full agenda for its annual general meeting scheduled for 10:00 a.m. on 27 May 2026 at the company’s headquarters...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117452562","title":"Haixi Pharma Schedules 27 May 2026 AGM; Agenda Covers 2025 Results, Board Restructure and New Share Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1117452562","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117452562?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:42","pubTimestamp":1777556571,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (Haixi Pharma) will convene its 2026 annual general meeting (AGM) on 27 May 2026 at 10:00 a.m. in Fuzhou, Fujian Province, the People’s Republic of China. Key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631344653","title":"Fujian Haixi Pharmaceuticals announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2631344653","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631344653?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:39","pubTimestamp":1777556374,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals will hold annual general meeting in Fuzhou, Fujian Province on May 27, 2026.Shareholders will vote on 2025 results items, including audited financial statements, annual report, final accounts plan, profit distribution plan, auditor reappointment, directors’ 2026 remuneration, bank credit facilities up to RMB 1 billion, guarantees up to RMB 300 million.Governance proposals include abolishing board of supervisors, amendments to articles of association, amendments to board procedures, amendments to shareholders’ meeting procedures, election of second-session directors.Capital actions include raising authorized capital of Hong Kong subsidiary to HKD 300 million, adoption of 2026 share incentive implementation plan, 20% general mandate to issue shares, 10% general mandate to repurchase shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, thi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL3c9JCR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192464408","title":"Stock Track | Haixi Pharma Soars 9.54% Intraday on Share Incentive Plan Announcement and Strong Fundamentals","url":"https://stock-news.laohu8.com/highlight/detail?id=1192464408","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192464408?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:40","pubTimestamp":1777513208,"startTime":"0","endTime":"0","summary":"Haixi Pharma's stock surged 9.54% during intraday trading, showing significant upward momentum in the market session.The company recently announced the adoption of an H-share incentive plan aimed at...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":73,"code":"91000000","status":"200"}]}}